Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020330 | PMC |
| http://dx.doi.org/10.1111/jdi.12207 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Commentary: Increasing accessibility and adaptability of healthy lifestyle interventions for youth survivors of childhood cancer.
J Pediatr Psychol
January 2025
Psychiatry and Behavioral Medicine, Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA, United States.
Invisible Monitoring for Athlete Health and Performance: A Call for a Better Conceptualization and Practical Recommendations.
Int J Sports Physiol Perform
January 2025
Department of Sport and Physical Activity, Faculty of Arts and Sciences, Edge Hill University, Ormskirk, United Kingdom.
Background: Practices to routinely monitor athletes are rapidly changing. With the concurrent exponential rise in wearable technologies and advanced data analysis, tracking training exposures and responses is widespread and more frequent in the athlete-coach decision-making process. Within this scenario, the concept of invisible monitoring emerged, which was initially vaguely defined as testing athletes without testing them.
View Article and Find Full Text PDFUnderstanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children.
Hum Vaccin Immunother
December 2025
Department of Health, Psychology and Social Care, University of Derby, Derby, UK.
The COVID-19 pandemic has significantly altered public perceptions of vaccines, particularly among parents. In high-income countries like the United Kingdom (UK) and Australia, factors such as misinformation, the expedited approval process of COVID-19 vaccines and unique local challenges have contributed to vaccine hesitancy, resulting in uneven uptake across various vaccination programs. Despite efforts like school-based influenza vaccination programs in the UK and free influenza vaccines in Australia, vaccination rates continue to decline.
View Article and Find Full Text PDFValidation of Quantitative Coronary Plaque Analysis at CT Angiography.
Radiol Cardiothorac Imaging
February 2025
Centre for Cardiovascular Science, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 SUF, United Kingdom.
Prescribing Psychostimulants for the Treatment of Stimulant Use Disorder: Navigating the Federal Legal Landscape.
J Addict Med
January 2025
From the Division of General Internal Medicine, San Francisco General Hospital, Department of Medicine, University of California San Francisco, San Francisco, CA (LWS); San Francisco Department of Public Health, San Francisco, CA (POC); Vital Strategies, New York, NY (KB, DC); Network for Public Health Law, Edina, MN (CSD); and New York University Grossman School of Medicine, New York, NY (CSD).
Stimulant use disorder (StUD) is a rapidly growing concern in the United States, with escalating rates of death attributed to amphetamines and cocaine. No medications are currently approved for StUD treatment, leaving clinicians to navigate off-label medication options. Recent studies suggest that controlled prescription psychostimulants such as dextroamphetamine, methylphenidate, and modafinil are associated with reductions in self-reported stimulant use, craving, and depressive symptoms.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!